STRATEC Biomedical Systems AG / Half Year Results/Preliminary Results
24.07.2008
Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
STRATEC publishes preliminary figures for first half of 2008 financial year
Birkenfeld, July 24, 2008
The Board of Management of STRATEC Biomedical Systems AG, which is listed
in the Prime Standard, hereby announces the preliminary unaudited
consolidated figures of the STRATEC Group for the first half of the 2008
financial year as of June 30, 2008 pursuant to IFRS (International
Financial Reporting Standards) and in accordance with Section 15 of the
German Securities Trading Act (WpHG).<pre>
Key Figures (EUR 000s) 01.01.- 06.30.2008 01.01.- 06.30.2007 Change
Sales 29,549 34,098 -13.3%
Gross performance 32,103 34,625 -7.3%
EBITDA 6,028 6,993 -13.8%
EBIT 4,874 5,897 -17.3%
EBT 5,059 5,907 -14.4%
Consolidated net income 3,873 4,185 -7.5%
Earnings per share (EUR) 0.34 0.37 -8.1%</pre>
Including temporary employees, the STRATEC Group had a total of 267
employees as of June 30, 2008 (previous year: 256).
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
Two major development and supply agreements were signed in the first six
months of the current financial year. Projects currently underway are
developing well on schedule, although we also witnessed acquisition-related
delays in outbound products being called up by one of our most important
customers. This resulted in a consolidation in sales and earnings during
the period under report which was within our range of expectations already
published. The key figures published by the company are comparable with
those for the strong first half of 2007, which was only marginally affected
by the aforementioned delays in product call-ups.
Based on the current, unchanged acceptance forecasts provided by our
customers, we expect to generate sales of between Euro 78 million and Euro
82 million and earnings before taxes (EBIT) of between Euro 16.2 million
and Euro 18.2 million for the 2008 financial year.
The long-term growth in our company is based on a large number of
development and supply contracts already agreed. The development status of
existing cooperation projects, as well as new customer orders currently
being initiated, give grounds to expect an ongoing positive business
performance.
The extensive interim report will be available for downloading from our
internet site from around 3 p.m. on August 14, 2008.
About STRATEC
STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de) designs
and manufactures fully automated analyzer systems for its partners in the
fields of clinical diagnostics and biotechnology. These partners market
such systems, in general together with their own reagents, to laboratories,
blood banks and research institutes around the world. The company develops
its products on the basis of its own patented technologies. Shares in the
company (ISIN: DE0007289001) are traded in the Prime Standard segment of
the Frankfurt Stock Exchange.
The STRATEC Group consists of the publicly listed parent company STRATEC
Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in
Germany, the USA, the UK, Switzerland and Romania.
Further information can be obtained from:
STRATEC Biomedical Systems AG
André Loy, Investor Relations
Gewerbestr. 37, 75217 Birkenfeld
Germany
Phone: +49 7082 7916 190
Fax: +49 7082 7916 999
Email: ir@stratec-biomedical.de
DGAP 24.07.2008
---------------------------------------------------------------------------
Language: English
Issuer: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail: info@stratec-biomedical.de
Internet: www.stratec-biomedical.de
ISIN: DE0007289001
WKN: 728900
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Stuttgart, München, Düsseldorf
End of News DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: STRATEC publishes preliminary figures for first half of 2008 financial year
| Source: EQS Group AG